EUVIMEDEUVIMED entdecken
Multizentrische Studie

The efficacy and survival impact of chidamide on angioimmunoblastic T‐cell lymphoma based on Epstein‐Barr virus stratification in the real world: A multicenter study

Xuemei Wang iD, Wanxi Yang, Hongyun Xing, Xiaodong Wang, Xinyu Xue, Jiao Yang, Caigang Xu

International Journal of Cancer · 2025

DOI: 10.1002/ijc.70251 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Xuemei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, Benzamides, Immunoblastic Lymphadenopathy. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein–Barr virus (EBV) infection is frequently observed in angioimmunoblastic T‐cell lymphoma (AITL), yet its prognostic and therapeutic implications remain unclear. This multicenter real‐world study analyzed 155 newly diagnosed AITL patients (117 EBV‐encoded RNA‐positive [EBER+] and 38 EBER‐negative [EBER−]) from Chinese institutions between 2012 and 2022. EBER+ cases demonstrated significantly higher Ki67 proliferation indices and CD30 expression compared to EBER− cases ( p = .013 and p = .045, respectively). While no survival difference was observed between EBER+ and EBER− groups (overall survival [OS] p = .16; progression‐free survival [PFS] p = .43), chidamide‐combined chemotherapy significantly improved outcomes exclusively in EBER+ patients (OS p = .014; PFS p = .0018) with no benefit seen in EBER− cases (OS p = .98; PFS p = .83). Multivariate analysis identified distinct risk factors by EBV status. Older age (≥60), thrombocytopenia (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanBenzamidesImmunoblastic LymphadenopathyLymphoma, T-CellAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleMiddle AgedAgedAdultPrognosisAged, 80 and overRetrospective StudiesYoung AdultRNA, ViralAminopyridines

Stichwörter der Autor:innen

Epstein–Barr virusangioimmunoblastic T‐cell lymphomachidamideprognostic factorsreal‐world study

Substanzen

N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamideBenzamidesRNA, ViralAminopyridines

Autor:innen und Institutionen

  • Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Department of Hematology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, Chengdu, China.
  • Chengdu Shang Jin Nan Fu Hospital/Shang Jin Hospital of West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Xuemei Wang

Zitieren

APA

Wang, X., Yang, W., Xing, H., Wang, X., Xue, X., Yang, J., & Xu, C. (2025). The efficacy and survival impact of chidamide on angioimmunoblastic T‐cell lymphoma based on Epstein‐Barr virus stratification in the real world: A multicenter study. International Journal of Cancer. https://doi.org/10.1002/ijc.70251

Vancouver

Wang X, Yang W, Xing H, Wang X, Xue X, Yang J, et al. The efficacy and survival impact of chidamide on angioimmunoblastic T‐cell lymphoma based on Epstein‐Barr virus stratification in the real world: A multicenter study. International Journal of Cancer. 2025. doi:10.1002/ijc.70251

BibTeX
@article{Wang2025,
  author = {Wang, Xuemei and Yang, Wanxi and Xing, Hongyun and Wang, Xiaodong and Xue, Xinyu and Yang, Jiao and Xu, Caigang},
  title = {The efficacy and survival impact of chidamide on angioimmunoblastic T‐cell lymphoma based on Epstein‐Barr virus stratification in the real world: A multicenter study},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.70251}
}
Kostenlos starten →